Viveve Medical, Inc. (VIVE)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Dec 27, 2024, 3:59 PM EST
Viveve Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
Net Income | -22.99 | -22.03 | -21.92 | -42.53 | -49.98 | -36.96 | Upgrade
|
Depreciation & Amortization | 0.81 | 1.14 | 1.3 | 1.18 | 0.79 | 0.45 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.09 | 0.11 | 0.02 | 0.11 | - | - | Upgrade
|
Stock-Based Compensation | 3.75 | 3.78 | 2.65 | 2.4 | 3.29 | 2.13 | Upgrade
|
Provision & Write-off of Bad Debts | 0.03 | 0.13 | 0.45 | 1.03 | 0.18 | -0.22 | Upgrade
|
Other Operating Activities | 0.66 | -0.38 | 2.37 | 8.28 | 1.58 | 1.05 | Upgrade
|
Change in Accounts Receivable | -0.38 | 0.1 | 0.35 | 3.1 | 0.33 | -3.9 | Upgrade
|
Change in Inventory | 0.9 | 2.21 | 1.36 | -1.07 | -1.99 | -0.07 | Upgrade
|
Change in Accounts Payable | -0.18 | 0.6 | -0.73 | -2.39 | -0.81 | 1.71 | Upgrade
|
Change in Other Net Operating Assets | 0.43 | 1.21 | -1.48 | -1.98 | 2.86 | 0.95 | Upgrade
|
Operating Cash Flow | -16.23 | -12.88 | -15.23 | -31.24 | -43.09 | -34.85 | Upgrade
|
Capital Expenditures | -0.6 | -0.46 | -0.78 | -1.09 | -2.14 | -0.91 | Upgrade
|
Investment in Securities | - | - | - | - | - | -2.5 | Upgrade
|
Investing Cash Flow | -0.6 | -0.46 | -0.78 | -1.09 | -2.14 | -3.41 | Upgrade
|
Long-Term Debt Issued | - | - | 1.34 | - | - | 29.21 | Upgrade
|
Total Debt Issued | - | - | 1.34 | - | - | 29.21 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | - | -10 | Upgrade
|
Total Debt Repaid | - | - | - | - | - | -10 | Upgrade
|
Net Debt Issued (Repaid) | - | - | 1.34 | - | - | 19.21 | Upgrade
|
Issuance of Common Stock | 0.07 | 26.04 | 8.75 | 18.32 | 58.15 | 34.93 | Upgrade
|
Repurchase of Common Stock | - | - | - | -0.01 | - | - | Upgrade
|
Other Financing Activities | 0 | -0.07 | -0.86 | -2.2 | -4.13 | -3.24 | Upgrade
|
Financing Cash Flow | 0.07 | 25.97 | 9.23 | 16.11 | 54.03 | 50.9 | Upgrade
|
Net Cash Flow | -16.76 | 12.64 | -6.79 | -16.22 | 8.79 | 12.64 | Upgrade
|
Free Cash Flow | -16.83 | -13.33 | -16.02 | -32.32 | -45.23 | -35.76 | Upgrade
|
Free Cash Flow Margin | -246.51% | -207.50% | -292.30% | -492.20% | -244.27% | -233.90% | Upgrade
|
Free Cash Flow Per Share | -1.58 | -1.32 | -10.18 | -259.03 | -1456.33 | -2043.66 | Upgrade
|
Cash Interest Paid | - | - | - | 2.51 | 2.67 | 2.07 | Upgrade
|
Cash Income Tax Paid | - | - | - | - | 0 | - | Upgrade
|
Levered Free Cash Flow | -7.57 | -6.51 | -8.01 | -20.16 | -28.58 | -22.75 | Upgrade
|
Unlevered Free Cash Flow | -6.88 | -5.89 | -7.44 | -17.44 | -25.85 | -20.77 | Upgrade
|
Change in Net Working Capital | -2.37 | -3.12 | -0.95 | 1.22 | -0.32 | 1.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.